Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients
暂无分享,去创建一个
[1] A. Hatzakis,et al. Immunogenicity of SARS-CoV-2 BNT162b2 Vaccine in People with Diabetes: A Prospective Observational Study , 2022, Vaccines.
[2] C. Balotta,et al. Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility , 2022, Vaccines.
[3] F. Diekmann,et al. Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patients , 2022, Journal of Nephrology.
[4] P. Shitrit,et al. Humoral response and breakthrough infections with SARS-CoV-2 B.1.617.2 variant in vaccinated maintenance hemodialysis patients , 2022, Journal of Nephrology.
[5] F. Maduell,et al. Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients , 2021, Clinical kidney journal.
[6] K. Nedeltchev,et al. Humoral Immune Response after the Third SARS-CoV-2 mRNA Vaccination in CD20 Depleted People with Multiple Sclerosis , 2021, Vaccines.
[7] L. Pickering,et al. Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer , 2021, Cancer Cell.
[8] L. Juillard,et al. A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis , 2021, Kidney International.
[9] P. von Landenberg,et al. Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study , 2021, Journal of clinical medicine.
[10] T. Bachelet,et al. Humoral response after SARS-CoV-2 mRNA vaccines in dialysis patients: Integrating anti-SARS-CoV-2 Spike-Protein-RBD antibody monitoring to manage dialysis centers in pandemic times , 2021, PloS one.
[11] K. Lhotta,et al. Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost , 2021, Kidney International.
[12] Zheng Wang,et al. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study , 2021, The Lancet Microbe.
[13] M. Preusser,et al. Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations. , 2021, JAMA oncology.
[14] F. Maduell,et al. Antibody maintenance 3 months after complete messenger RNA COVID-19 vaccination in haemodialysis patients , 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] J. Chinen,et al. Secondary immunodeficiencies. An overview. , 2021, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[16] V. Caudwell,et al. SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis , 2021, American Journal of Kidney Diseases.
[17] F. Maduell,et al. Weekly seroconversion rate of the mRNA-1273 SARS-CoV-2 vaccine in haemodialysis patients. , 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[18] G. Piccoli,et al. Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis , 2021, Clinical kidney journal.
[19] T. Tonn,et al. Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant , 2021, Transplantation.
[20] C. Courivaud,et al. Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis , 2021, Kidney International.
[21] F. Maduell,et al. Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients , 2021, American Journal of Kidney Diseases.
[22] L. Rénia,et al. COVID-19 vaccines and kidney disease , 2021, Nature Reviews Nephrology.
[23] J. Dogné,et al. Antibody titres decline 3-month post-vaccination with BNT162b2 , 2021, Emerging microbes & infections.
[24] E. Montagud-Marrahi,et al. SARS-CoV-2 Infection in a Spanish Cohort of CKD-5D Patients: Prevalence, Clinical Presentation, Outcomes, and De-Isolation Results , 2020, Blood Purification.
[25] F. Maduell,et al. Prevalence of COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening. , 2020, Journal of the American Society of Nephrology : JASN.
[26] P. Kelleher,et al. High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening. , 2020, Journal of the American Society of Nephrology : JASN.
[27] Junhua Li,et al. Lessons from the Experience in Wuhan to Reduce Risk of COVID-19 Infection in Patients Undergoing Long-Term Hemodialysis. , 2020, Clinical journal of the American Society of Nephrology : CJASN.
[28] T. Eleftheriadis,et al. Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients. , 2014, World journal of gastroenterology.
[29] L. Bracci,et al. Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer , 2013, Cell Death and Differentiation.
[30] D. Abramowicz,et al. Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[31] T. Eleftheriadis,et al. Basic Science and Dialysis: Disturbances of Acquired Immunity in Hemodialysis Patients , 2007, Seminars in dialysis.
[32] A. Pani,et al. Immunosuppressive treatment in dialysis patients. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] J. Bargman,et al. Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: results of a decision analysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] OUP accepted manuscript , 2021, Nephrology Dialysis Transplantation.